RankAlpha logo
Back to Rankings

CLRB

Cellectar BiosciencesC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The reported CLOVER-WaM subset responses and progress toward a confirmatory study support a potentially valuable regulatory path if Cellectar executes enrollment and files as planned. [#SEC-8K-2026-08-13] SEC-filed earnings exhibit
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Cytopenias were the reported Grade 3-or-higher adverse event in that subset. [#SEC-8K-2026-08-13]
Momentum
69
Value
57
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.05 · Bull $2.50 · Bear $0.50Analysis 2026-10-15; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-26

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $11.50
Why
Momentum69 · Δ7d -
Value57 · Δ7d +0.0
Sentiment49 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta +0.0.

Contradictions & invalidation

  • • Cytopenias were the reported Grade 3-or-higher adverse event in that subset. [#SEC-8K-2026-08-13]
  • • Peer comparability and independently verified analyst coverage are limited.
  • • The principal program still faces trial, regulatory and funding risk.

Catalyst clock

2026-10-15

October 15 CLOVER-WaM presentation

Lead driver: Value · See fundamentals
Momentum
69
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.7
Sentiment
49
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 69.2 / Value 56.7 / Sentiment 49.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-15. Scenario method

B+
Bull case
20%
Probability
Target price
$2.50
Analysis reference price unavailable
Analysis 2026-10-15 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$1.05
Analysis reference price unavailable
Analysis 2026-10-15 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.50
Analysis reference price unavailable
Analysis 2026-10-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$11.44M
Beta
0.30
Shares Out
9.45M
P/E (TTM) · Derived
-0.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.30
Rev YoY
-
EPS YoY
-83.3%
Gross Margin
-
Op Margin
-
Net Debt
-$12.79M
Current Ratio
6.66
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data